BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2230471)

  • 21. Coming of age: recombinant human thyroid-stimulating hormone as a preparation for (131)i therapy in thyroid cancer.
    Robbins RJ; Pentlow KS
    J Nucl Med; 2003 Jul; 44(7):1069-71. PubMed ID: 12843222
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hemorheologic monitoring of thyroid cancer patients treated with mega-radioiodine therapy].
    Költringer P; Eber O; Lind P; Langsteger W; Klima K
    Radiobiol Radiother (Berl); 1988; 29(2):245-7. PubMed ID: 3399666
    [No Abstract]   [Full Text] [Related]  

  • 23. Session on: has [131I]metaiodobenzylguanidine a role in the treatment of medullary thyroid cancer and carcinoid tumors? Chairman's report.
    Bestagno M
    J Nucl Biol Med (1991); 1991; 35(4):355-6. PubMed ID: 1823857
    [No Abstract]   [Full Text] [Related]  

  • 24. Differentiated thyroid carcinoma (DTC) in the elderly: disease outcome, therapeutic approach, and long-term results in a group of 314 patients.
    Girelli ME; Casara D; Rubello D; Mazzarotto R; Saladini G; Busnardo B
    J Endocrinol Invest; 1999; 22(10 Suppl):45-6. PubMed ID: 10727040
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment and follow-up of thyroid cancer].
    Välimäki M
    Duodecim; 1991; 107(6):456-60. PubMed ID: 1364893
    [No Abstract]   [Full Text] [Related]  

  • 26. Quantitative approach to radioiodine ablation of thyroid remnants following surgery for thyroid cancer.
    Hadjieva T
    Radiobiol Radiother (Berl); 1985; 26(6):819-23. PubMed ID: 4095270
    [No Abstract]   [Full Text] [Related]  

  • 27. Presentation and practical management to optimize radioiodine treatment of well differentiated thyroid cancer: ablation of thyroid remnants with radioiodine.
    Janisch A; Altenbrunn HJ; Markwardt J
    Radiobiol Radiother (Berl); 1987; 28(5):707-10. PubMed ID: 3441634
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of thyroid cancer with distant metastases].
    Stoenescu D; Damian A; Oproiu A; Handoca A; Cernăianu N
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1977; 26(5):333-9. PubMed ID: 145614
    [No Abstract]   [Full Text] [Related]  

  • 29. [Non-surgical treatment of thyroid neoplasms].
    Klepp O
    Tidsskr Nor Laegeforen; 1975 Aug; 95(23):1287-90. PubMed ID: 1179338
    [No Abstract]   [Full Text] [Related]  

  • 30. [Polycytostatic treatment of highly aggressive thyroid malignomas].
    Zechmann W; Riccabona G
    Z Allgemeinmed; 1975 Oct; 51(29):1304-7. PubMed ID: 1199156
    [No Abstract]   [Full Text] [Related]  

  • 31. Complications, sequela and dosimetry of iodine-131 therapy for thyroid carcinoma.
    Bushnell DL; Boles MA; Kaufman GE; Wadas MA; Barnes WE
    J Nucl Med; 1992 Dec; 33(12):2214-21. PubMed ID: 1460519
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of tumors of the thyroid gland].
    Blancher G
    Cah Coll Med Hop Paris; 1968 Dec; 9(14):1179-84. PubMed ID: 4195896
    [No Abstract]   [Full Text] [Related]  

  • 33. Papillary and follicular thyroid carcinoma.
    Schlumberger MJ
    N Engl J Med; 1998 Jan; 338(5):297-306. PubMed ID: 9445411
    [No Abstract]   [Full Text] [Related]  

  • 34. [Surgical and postsurgical therapy of differentiated carcinomas of the thyroid].
    Pandolfi C
    Minerva Med; 1986 Jul; 77(28-29):1355-7. PubMed ID: 3526193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Surgical treatment of recurrent goiter].
    Sedov VM; Sedletskiĭ IuI; Belianina EO
    Vestn Khir Im I I Grek; 1999; 158(5):53-6. PubMed ID: 10645583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [After care of differentiated thyroid gland carcinoma with special reference to serum thyroglobulin level].
    Kanitz W; Böttger IG; Pabst HW; Heidenreich P; Dirr W
    Rofo; 1987 Sep; 147(3):282-7. PubMed ID: 2823333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of thyroid cancer in childhood and adolescence from a radiologic viewpoint].
    Gottschild D; Zinner G; Langbein T; Newmann G; Wünsche A; Schneider G
    Radiobiol Radiother (Berl); 1986; 27(6):709-20. PubMed ID: 3575679
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current trends in the treatment of thyroid cancer].
    Damian A; Stoenescu D; Oproiu A; Handoca A; Cernăianu N
    Endocrinologie; 1978; 16(2):83-7. PubMed ID: 675131
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison of 30mCi and higher doses of iodine-131 for postoperative thyroid remnant ablation].
    Liu RT; Huang MJ; Huang HS; Huang BY; Lin JD; Wang PW; Tzen KY
    Taiwan Yi Xue Hui Za Zhi; 1987 May; 86(5):524-8. PubMed ID: 3625158
    [No Abstract]   [Full Text] [Related]  

  • 40. Results of [131I]metaiodobenzylguanidine therapy administered to two patients with medullary carcinoma of the thyroid.
    Schvartz C; Delisle MJ
    J Nucl Biol Med (1991); 1991; 35(4):332-3. PubMed ID: 1823850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.